Dr. Raymond H.m. Schaerf, MD

Dr. Schaerf practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Schaerf's NPI, 1912903295, was assigned on June 22, 2005. Dr. Schaerf graduated from New York Medical College in 1972. Dr. Schaerf holds California license 208G00000X.

Dr. Schaerf's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Schaerf's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schaerf practices. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Schaerf's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Schaerf is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dmand AI has Dr. Schaerf's licenses on file in 4 states: California, Connecticut, Pennsylvania and Florida.

CMS data shows 116 Medicare services from Dr. Schaerf across 6 procedure codes in 2024, for 62 Medicare patients. Medicare paid $40,225 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 62 Medicare patients who saw Dr. Schaerf in 2024. The largest group is 75 to 84, with 27 patients. 75% of them have heart failure, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 3.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schaerf's median patient age at 71, with 34% women.

In 2024, Dr. Schaerf wrote 14 Medicare Part D claims. 86% of them were for generic drugs. They cover 1 drug, with $107 in total drug cost. In 2021, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Schaerf for performance year 2024, reported as part of a group. Dr. Schaerf accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 70 procedures of pacemaker insertion or repair by Dr. Schaerf, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Schaerf, published from 2009 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Device Removal, Pacemaker, Artificial and Electrodes, Implanted. Dr. Schaerf has published most often in Heart Rhythm. Dr. Schaerf's most frequent co-authors are Laurence M. Epstein, MD, John Kenneth Conrad, MD and Kimberly E. Costas, MD.

Dmand AI links Dr. Schaerf to 3 clinical trials. Conditions studied include Bradycardia, Tachycardia and Tachycardia, Ventricular. Abbott Medical Devices sponsors the most, 3. Open Payments lists research payments to Dr. Schaerf that name 3 trials.

CMS Open Payments shows 455 general payments to Dr. Schaerf from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. AngioDynamics, Inc. paid the most, $165,836. It also lists 57 research payments totaling $153,089 from 2016 to 2020, naming 3 clinical trials.

Dmand AI lists 4 awards for Dr. Schaerf, most recently CMS Stage 1 EHR in 2013.

Dr. Schaerf graduated from New York Medical College in 1972. Dr. Schaerf is a member of STS.

Dr. Schaerf is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.